PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Enriched seaweed extract (ESE) resulted in the complete inhibition of infection in plaque reduction assays and reduced virus-cell binding by 79.3% [PMID:39772226]
Phlorotannin-rich extracts significantly lowered serum fasting blood sugar, AST, ALT, total cholesterol, triacylglyceride, and free fatty acids in HED-induced hyperlipidemia rats [PMID:36364926]
Oral administration of A. nodosum reduces calculus and plaque accumulation, with powder form showing the strongest preventive action [PMID:37727971]
Clinical evidence supports the use of A. nodosum extract in facial cosmetics for sensitive skin [PMID:34436303]
Evidence base relies mainly on cell line and small animal models, with few human studies to date [PMID:33573121]
Safety & adverse effects
Pregnancy & lactation
Evidence summary
PubMed sources
- 1.PMID: 30000910 (2006) — Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies. · Frontiers in nutrition
- 2.PMID: 37727971 (2023) — Ascophyllum nodosum as a nutrient supporting oral health in dogs and cats: a review. · Polish journal of veterinary sciences
- 3.PMID: 42085785 (2026) — Mitigating the impact of salinity and/or bisphenol A stress on the performance of the tomato crop by spraying with an algal extract of Ascophyllum nodosum L. · Journal of hazardous materials
- 4.PMID: 39958388 (2023) — Non-alcoholic fatty liver disease: Dietary and nutraceutical approaches. · Liver research (Beijing, China)
- 5.PMID: 39772226 (2024) — Phlorotannin-Rich Ascophyllum nodosum Seaweed Extract Inhibits Influenza Infection.